1,4-Butanediol

1,4-Butanediol

SCHEMBL1357797

C=COC.OCCCCO

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,6-Hexanediol SCHEMBL4138196 0.97 LMNA (0.43) SMN1; SMN2LMNAALDH1A1TSHRHSD17B10
Ethylene Glycol SCHEMBL195252 0.87
Ethylene Glycol SCHEMBL12541029 0.84 TSHR (0.33) TSHR
Ethylene Glycol SCHEMBL16005400 0.84
Ethylene Glycol SCHEMBL12540602 0.84 TSHR (0.33) TSHR
Ethylene Glycol SCHEMBL15390275 0.84 TSHR (0.33) TSHR
Ethylene Glycol SCHEMBL4147190 0.81 TSHR (0.32) TSHR
Alcohol SCHEMBL8504348 0.80
Vinyl Ether SCHEMBL5831874 0.79 TSHR (0.30) TSHR
Ethylene Glycol SCHEMBL4135001 0.79 TSHR (0.30) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103289401-B Polyimide precursor composition, polyimides molded body and image processing system 富士施乐株式会社 2016-12-28 CN disclosed
US-9193828-B2 Polyimide precursor composition, polyimide-molded product, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2015-11-24 US disclosed
US-8859186-B2 Polyimide precursor, resin composition comprising the polyimide precursor, pattern forming method using the resin composition, and articles produced by using the resin composition DAI NIPPON PRINTING CO., LTD. (JP) 2014-10-14 US disclosed
US-20130230724-A1 POLYIMIDE PRECURSOR COMPOSITION, POLYIMIDE-MOLDED PRODUCT, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-09-05 US disclosed
US-20110281218-A1 POLYIMIDE PRECURSOR, RESIN COMPOSITION COMPRISING THE POLYIMIDE PRECURSOR, PATTERN FORMING METHOD USING THE RESIN COMPOSITION, AND ARTICLES PRODUCED BY USING THE RESIN COMPOSITION DAI NIPPON PRINTING CO., LTD. (JP) 2011-11-17 US disclosed
US-20090263745-A1 POLYIMIDE PRECURSOR, RESIN COMPOSITION COMPRISING THE POLYIMIDE PRECURSOR, PATTERN FORMING METHOD USING THE RESIN COMPOSITION, AND ARTICLES PRODUCED BY USING THE RESIN COMPOSITION DAI NIPPON PRINTING CO., LTD. (JP) 2009-10-22 US disclosed
US-20090010603-A1 Resin Composition for Optical Packaging Material and Process for Preparing the Same, and Optical Packaging Material, Optical Packaging Component, and Optical Module NIPPON SHOKUBAI CO., LTD. (JP) 2009-01-08 US disclosed
CN-1454400-A Polymer solid electrolyte and battery using the same DAINIPPON INK & CHEMICALS (JP) 2003-11-05 CN disclosed
EP-1339127-A1 SOLID POLYMER ELECTROLYTE AND CELL CONTAINING THE ELECTROLYTE DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090263745-A1 POLYIMIDE PRECURSOR, RESIN COMPOSITION COMPRISING THE POLYIMIDE PRECURSOR, PATTERN FORMING METHOD USING THE RESIN COMPOSITION, AND ARTICLES PRODUCED BY USING THE RESIN COMPOSITION TERB1, PUF60, CD79B SMN1; SMN2 3054/4885LMNA 3161/4885ALDH1A1 2911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.